Online ISSN: 2149-3189
2015
Monthly
Nicaea Medical Publishing
Türkiye

Association Between Kidney Function and Morphology–Voltage–P Wave Duration (MVP) Score: A Cross-Sectional Electrocardiographic Study

Ömer Doğan, Abdullah Ömer Ebeoğlu, Şevval İlke Ebeoğlu, Ümit Acar, Hasan Ali Barman
DOI
https://doi.org/10.18621/eurj.1844291
Abstract
Objectives: Chronic kidney disease (CKD) is associated with a high burden of atrial arrhythmias, primarily atrial fibrillation (AF), due to structural and electrical remodelling of the atria. The Morphology–Voltage–P wave duration (MVP) score, a composite electrocardiographic parameter derived from surface electrocardiography (ECG), has been proposed as a simple, non-invasive marker of atrial electrical dysfunction. However, its relationship with renal function has not been previously explored.
Methods: This single-centre, retrospective, cross-sectional study included 90 adults with varying levels of estimated glomerular filtration rate (eGFR). MVP scores were calculated from standard 12-lead ECGs, and echocardiographic, demographic, and laboratory variables were recorded. Patients were grouped by eGFR (>60, 30–59, and <30 mL/min/1.73 m²). Correlation and multiple linear regression analyses were performed to identify independent predictors of MVP score.
Results: MVP score increased across worsening eGFR categories (1.33±0.61, 2.63±1.03, and 4.64±1.26, respectively; P<0.001). A strong inverse correlation was observed between eGFR and MVP score (r = –0.774, P<0.001). In multivariable analysis, eGFR (β = –0.519, P<0.001), left atrial diameter (β=0.396, P<0.001), and male sex (β=0.133, P=0.029) were independent determinants of higher MVP values, explaining 63% of MVP variance.
Conclusions: Reduced renal function is independently associated with higher MVP scores, reflecting atrial electrical abnormalities in patients with CKD. The MVP score may serve as a low-cost, easily applicable ECG marker for early detection of subclinical atrial dysfunction and arrhythmia risk in patients with renal impairment. Prospective, multicentre studies integrating MVP with advanced imaging and artificial intelligence–based ECG analysis are warranted to validate its clinical utility.
Keywords
Morphology-Voltage-P Wave Duration (MVP) Score, Chronic Kidney Disease, Atrial Electrical Remodelling
References

1. Zhang D, Feng Y, Leung FC, Wang L, Zhang Z. Does Chronic Kidney Disease Result in High Risk of Atrial Fibrillation? Front Cardiovasc Med. 2019;6:82. doi: 10.3389/fcvm.2019.00082.

2. Kim SM, Jeong Y, Kim YL, et al. Association of Chronic Kidney Disease With Atrial Fibrillation in the General Adult Population: A Nationwide Population-Based Study. J Am Heart Assoc. 2023;12(8):e028496. doi: 10.1161/JAHA.122.028496.

3. Power DA, Lampert J, Camaj A, et al. Cardiovascular Complications of Interatrial Conduction Block: JACC State-of-the-Art Review. J Am Coll Cardiol. 2022;79(12):1199-1211. doi: 10.1016/j.jacc.2022.01.030.

4. Alexander B, Milden J, Hazim B, et al. New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration). Ann Noninvasive Electrocardiol. 2019;24(6):e12669. doi: 10.1111/anec.12669.

5. Hayıroğlu Mİ, Çınar T, Selçuk M, et al. The significance of the morphology-voltage-P-wave duration (MVP) ECG score for prediction of in-hospital and long-term atrial fibrillation in ischemic stroke. J Electrocardiol. 2021;69:44-50. doi: 10.1016/j.jelectrocard.2021.09.006.

6. Yang N, Yan N, Cong G, Yang Z, Wang M, Jia S. Usefulness of Morphology-Voltage-P-wave duration (MVP) score as a predictor of atrial fibrillation recurrence after pulmonary vein isolation. Ann Noninvasive Electrocardiol. 2020;25(6):e12773. doi: 10.1111/anec.12773.

7. Kahyaoglu M, Gecmen C, Candan O, et al. The usefulness of morphology-voltage-P wave duration ECG score for predicting early left atrial dysfunction in hypertensive patients. Clin Exp Hypertens. 2021;43(6):572-578. doi: 10.1080/10641963.2021.1916945.

8. Pay L, Yumurtaş AÇ, Tezen O, et al. Efficiency of MVP ECG Risk Score for Prediction of Long-Term Atrial Fibrillation in Patients With ICD for Heart Failure With Reduced Ejection Fraction. Korean Circ J. 2023;53(9):621-631. doi: 10.4070/kcj.2022.0353.

9. Xing LY, Diederichsen SZ, Højberg S, et al. Electrocardiographic Morphology-Voltage-P-Wave-Duration (MVP) Score to Select Patients for Continuous Atrial Fibrillation Screening to Prevent Stroke. Am J Cardiol. 2023;205:457-464. doi: 10.1016/j.amjcard.2023.08.042.

10. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.

11. Inker LA, Eneanya ND, Coresh J, et al; Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737-1749. doi: 10.1056/NEJMoa2102953.

12. Rapa SF, Di Iorio BR, Campiglia P, Heidland A, Marzocco S. Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2019;21(1):263. doi: 10.3390/ijms21010263.

13. Dumler F, Kilates C. Body composition analysis by bioelectrical impedance in chronic maintenance dialysis patients: comparisons to the National Health and Nutrition Examination Survey III. J Ren Nutr. 2003;13(2):166-172. doi: 10.1053/jren.2003.50022.

14. Gadde S, Kalluru R, Cherukuri SP, Chikatimalla R, Dasaradhan T, Koneti J. Atrial Fibrillation in Chronic Kidney Disease: An Overview. Cureus. 2022;14(8):e27753. doi: 10.7759/cureus.27753.

15. Qiu H, Ji C, Liu W, et al. Chronic Kidney Disease Increases Atrial Fibrillation Inducibility: Involvement of Inflammation, Atrial Fibrosis, and Connexins. Front Physiol. 2018;9:1726. doi: 10.3389/fphys.2018.01726.

16. Huang JC, Wei SY, Chen SC, et al. P wave dispersion and maximum P wave duration are associated with renal outcomes in chronic kidney disease. PLoS One. 2014;9(7):e101962. doi: 10.1371/journal.pone.0101962.

17. Kumar Pandey U, Chaudhary N, Singh S. Utility of P Wave Indices on Electrocardiography in Predicting the Left Atrial Volume Index in Chronic Kidney Disease Patients. Cureus. 2025;17(1):e77809. doi: 10.7759/cureus.77809.

18. Law JP, Pickup L, Pavlovic D, Townend JN, Ferro CJ. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. J Hum Hypertens. 2023;37(1):1-19. doi: 10.1038/s41371-022-00751-4.

19. Istolahti T, Eranti A, Huhtala H, et al. The prevalence and prognostic significance of interatrial block in the general population. Ann Med. 2020;52(3-4):63-73. doi: 10.1080/07853890.2020.1731759.

20. Murariu E, Frigy A. Bayés' Syndrome-A Comprehensive Short Review. Medicina (Kaunas). 2020;56(8):410. doi: 10.3390/medicina56080410.

There are 20 references in total.
How to Cite
1.
Doğan Ömer, Ebeoğlu A Ömer, Ebeoğlu Şevval İlke, Acar Ümit, Barman HA. Association Between Kidney Function and Morphology–Voltage–P Wave Duration (MVP) Score: A Cross-Sectional Electrocardiographic Study. Eur Res J. 2026;12(3):305-314. doi:10.18621/eurj.1844291
License
Creative Commons License

Copyright (c) 2026 The European Research Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

View Volume 12 - Issue 3 (March 2026)

Volume 12 - Issue 3 (March 2026)

Article Information

  • File Downloads 8
  • Abstract Views 42
  • Altmetrics
  • Share
Download data is not yet available.